Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...

Radiopharmaceutical development and clinical translation face numerous scientific, ethical, and regulatory challenges, particularly within the pediatric population. Although molecular imaging holds ...

The FDA recommends prioritizing overall survival as a primary endpoint in oncology trials, especially for diseases with short natural histories or existing OS-prolonging treatments. Trials should ...

We stand at an extraordinary crossroads in medicine. This year, a young patient at Children's Hospital of Philadelphia received a treatment that would have been pure science fiction just decades ago — ...

The term ‘mainstreaming’ was first used in 2003 by the Secretary of State for Health in the context of the genetics white paper Our Inheritance, Our Future when he argued that genomics must move from ...

In a typical undergraduate biochemistry course, two main educational objectives include (1) understanding and applying how genetic mutations can influence protein structure and function, and (2) ...

Evolent (NYSE: EVH) is a company built to help payers manage high-cost specialty care, focusing on areas such as oncology, cardiology, and musculoskeletal medicine. In the Journal of Clinical Pathways ...

For many healthtech innovators the real adoption challenge is not always in proving the clinical value of their product. It is overcoming structural barriers that stand in their way. So, let’s explore ...

1 City St George's, University of London, London, UK Background NICE Guideline NG241: identifying and managing familial and genetic risk of ovarian cancer (OC) was published by the National Institute ...